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ABSTRACT: Exposure of myosin subfragment 1 (S1) to 3-morpholinosydnonimine (SIN-1) produced a
time-dependent inhibition of the F-actin-stimulated S1 Mg2+-ATPase activity, reaching 50% inhibition
with 46.7 ( 8.3 íM SIN-1 for 8.7 íM S1, that is, at a SIN-1/S1 molar ratio of approximately 5.5. The
inhibition was due to the peroxynitrite produced by SIN-1 decomposition because (1) decomposed SIN-1
was found to have no effect on S1 ATPase activity, (2) addition of SIN-1 in the presence of superoxide
dismutase and catalase fully prevented inhibition by SIN-1, and (3) micromolar pulses of chemically
synthesized peroxynitrite produced inhibition of F-actin-stimulated S1 Mg2+-ATPase activity. In parallel,
SIN-1 produced the inhibition of the nonphysiological Ca2+-dependent and K+/EDTA-dependent S1 ATPase
activity of S1 and, therefore, suggested that the inhibition of F-actin-stimulated S1 Mg2+-ATPase activity
is produced by the oxidation of highly reactive cysteines of S1 (Cys707 and Cys697), located close to the
catalytic center. This point was further confirmed by the titration of S1 cysteines with 5,5′-dithiobis(2-
nitrobenzoic acid) and by the parallel decrease of Cys707 labeling by 5-(iodoacetamido)fluorescein, and it
was reinforced by the fact that other common protein modifications produced by peroxynitrite, for example,
protein carbonyl and nitrotyrosine formation, were barely detected at the concentrations of SIN-1 that
produced more than 50% inhibition of the F-actin-stimulated S1 Mg2+-ATPase activity. Differential
scanning calorimetry of S1 (untreated and treated with different SIN-1 concentrations) pointed out that
SIN-1, at concentrations that generate micromolar peroxynitrite fluxes, impaired the ability of ADPâV1 to
induce the intermediate catalytic transition state and also produced the partial unfolding of S1 that leads
to an enhanced susceptibility of S1 to trypsin digestion, which can be fully protected by 2 mM GSH.
Impairment of muscle contraction has been reported upon
exposure of muscle cells to chronic oxidative stress condi-
tions, and it has been proposed that it is, at least in part, the
result of oxidative modification of myofibril proteins (1, 2).
A high sensitivity of muscle myofibrils to free-radical-
mediated oxidative stress had been noticed by Nagasawa
et al. (3), who showed that skeletal muscle actin and
myosin become oxidized in vivo following Fe-nitrilo-
triacetate treatment in rats, an experimental model for iron
overload. Furthermore, Andrade et al. (4) have shown that
exposure of muscle fibers to low peroxide concentrations
induced an altered cross-bridge kinetics. Because peroxy-
nitrite is a major oxidative agent in ischemia/reperfusion
insults such as heart infarct or atrial fibrillation (1, 5, 6) and
produces a reaction likely to be irreversible in vivo, the
nitration of protein tyrosines to 3-nitrotyrosine (7-9), the
level of protein nitration has gained acceptance as a finger-
print of in vivo peroxynitrite-mediated oxidative-stress
damage (8). Recent studies have shown that myosin is one
of the muscle proteins showing higher levels of 3-nitroty-
rosine after atrial fibrillation (1, 6) and aging (10). However,
despite muscle myosin being a major and particularly
relevant component of myofibrils, myosin sensitivity to
peroxynitrite-induced oxidative stress and the functional and
structural consequences of its modification by peroxynitrite
have not been worked out and deserve to be studied.
Peroxynitrite is a strong oxidant (E0′ ) 1.2-1.4 V (11))
and can directly produce the oxidation of protein cysteines
to thiyl radicals, disulfides, and eventually sulfenic acid (12,
13), although at physiological pH, the two-electron oxidation
leading to disulfides predominates (8), and to a lesser extent,
peroxynitrite can oxidize other amino acids leading to protein
carbonyl formation (14). Protein-cysteine oxidation by per-
oxynitrite has been shown to cause the inhibition of sarco-
plasmic-reticulum Ca2+ ATPase (15, 16). In addition,
peroxynitrite can modify proteins by acting through radicals
generated during its spontaneous decomposition in biochemi-
cal buffers and biological fluids, particularly, HOâ and NO2â,
a reaction pathway that is potentiated by the presence of
bicarbonate, which upon reaction with peroxynitrite leads
to the production of carboxylate radical CO3â- (17, 18). One
characteristic product of this reaction pathway in proteins is
3-nitrotyrosine. It has been reported that nitration of tyrosines
close to the catalytic center can at least in part account for
the inhibition of the activity of several enzymes by per-
oxynitrite (9). In addition, oxidation of amino acid side chains
leading to protein carbonyls can also be produced through
this radical pathway (19).
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SIN-11 has been widely used to mimic the effects of
chronic exposure of cells in culture to peroxynitrite oxidative
stress (20, 21). SIN-1 slowly decomposes in neutral and
weakly alkaline water solutions, releasing nitric oxide and
superoxide anion (22), which react with each other to produce
peroxynitrite with a second-order rate constant of 4-7 
109 M-1âs-1, close to the diffusion limit for chemical
reactions (8, 23). Because of the short lifetime of peroxy-
nitrite at physiological pH, less than 1 s in buffer solutions
at pH 7 (8) and less than 0.1 s in cytosol (11, 24), and
because synthetic peroxynitrite needs to be stored in highly
alkaline solutions (i.e., 1.5 M NaOH) (12), SIN-1 offers clear
advantages over synthetic peroxynitrite for carrying out
studies on the effects of the exposure of cells and subcellular
components to submicromolar or micromolar fluxes of per-
oxynitrite at a duration of 30 min to 2 h (25), an oxidative
stress that can be attained during inflammation and ischemia/
reperfusion episodes (8, 26). Moreover, the kinetics of per-
oxynitrite generation and the peroxynitrite concentration
attained in the solution during SIN-1 decomposition can be
reliably monitored in the buffered solutions commonly used
for biochemical studies with isolated subcellular components
(25).
The head segment of myosin, named subfragment 1 or
S1, can be produced by limited chymotrypsin digestion and
purified by following well-established protocols (27, 28). S1
contains the binding sites for ATP and actin and is the protein
domain responsible for the myosin-ATPase activity during
muscle contraction (29). During myosin-ATPase activity, S1
cycles through an intermediate state M**âADPâPi (30, 31).
Vanadate inhibits myosin-ATPase activity by forming, in the
absence of actin, a very stable complex with MgADP that
mimics this transition M**âADPâPi intermediate state (30).
The addition of ADPâV1 and ADPâAlF4 (200 íM) along with
a short incubation time (usually less than 30 min) has been
used to mimic the intermediate activated M**âADPâPi state
(32-34).
In this work, we report that exposure of S1 to synthetic
peroxynitrite or to submicromolar and micromolar peroxy-
nitrite concentrations generated with SIN-1 produced strong
inhibition of the F-actin-stimulated S1 Mg2+-ATPase activity,
which correlated with the impairment of the ability of S1 to
reach the obligatory catalytic cycle intermediate state M**â
ADPâPi and the protein unfolding at the highest SIN-1
concentrations studied. The relevance of cysteine oxidation,
3-nitrotyrosines, and protein carbonyl formation to S1
inhibition induced by the exposure of S1 to peroxynitrite
has also been studied.
MATERIALS AND METHODS
Purification of Myosin and Preparation of S1. Myosin and
S1 have been prepared as indicated by Tiago et al. (35).
Briefly, myosin was prepared from leg and dorsal white-
rabbit skeletal muscle, as previously described by Pires et
al. (36). Subfragment 1 (S1) was prepared by the chymo-
tryptic digestion of myosin according to Margossian and
Lowey (28). F-Actin was prepared from an acetone powder
of rabbit skeletal muscle as described by Pardee and Spudich
(37). Protein concentrations were determined spectrophoto-
metrically by using extinction coefficients of E1%280 ) 5.7
cm-1 for myosin, E1%280 ) 7.5 cm-1 for S1, and E1%290 )
11.5 cm-1 for actin. The molecular masses used were 500,
115, and 42 kDa for myosin, S1, and actin, respectively.
Measurement of Peroxynitrite Produced during SIN-1
Decomposition and Preparation of Synthetic Peroxynitrite.
The production of peroxynitrite during SIN-1 decomposition
has been calculated from the kinetics of oxidation of NADH,
continuously monitored by the decay of absorbance at 340
nm and the efficiency of peroxynitrite detection by NADH
(80% in our assays), as in Martı´n-Romero et al. (25) and
Gutie´rrez-Martı´n et al. (21). As described therein, the time
course of the total peroxynitrite released by SIN-1 can be
obtained by integrating the area below the curve up to
different times, and the peroxynitrite flux per minute at
different times during SIN-1 decomposition can be obtained
from the slope of the plot of total peroxynitrite versus time.
Peroxynitrite was synthesized according to the method
described by Radi et al. (12) and briefly outlined in a
previous study (38). The peroxynitrite solution was split into
small aliquots and frozen at less than -25 °C until use.
Peroxynitrite concentration was measured spectrophotometri-
cally in aliquots defrosted immediately before the experi-
ments reported in this article using an extinction coefficient
of 1670 M-1âcm-1 at 302 nm in 1.5 M NaOH (19).
Measurement of Mg2+-ATPase, Ca2+-ATPase, and K+/
EDTA-ATPase ActiVities. Steady-state assays of Mg2+-
ATPase and actin-activated S1 ATPase were measured
spectrophotometrically at 25 °C using the coupled-enzyme-
pyruvate-kinase/lactate-dehydrogenase assay (39) with the
following reaction mixture: 20 mM Hepes (pH 7.0), 2.5 mM
MgCl2, 2 mM ATP, 0.42 mM phosphoenolpyruvate, 0.375
mM NADH, 18 U of lactate dehydrogenase, and 18 U of
pyruvate kinase, as described in the literature (35). F-Actin-
stimulated S1 Mg2+-ATPase activity was measured by
supplementing the previous assay medium with a nearly 4.4-
fold molar excess of F-actin over S1, unless indicated
otherwise (2 íM F-actin and 0.45 íM S1), and we obtained
an average activity of 1.64 ( 0.05 ímol of product min-1
(mg of S1)-1 (n > 10 S1 and F-actin preparations). Under
these experimental conditions, F-actin stimulated the basal
Mg2+-ATPase activity of S1 approximately 20-fold, that is,
the basal S1 Mg2+-ATPase activity was on average 0.085 (
0.005 ímol of product min-1 (mg of S1)-1.
Nonphysiological ATPase activities (Ca2+- and K+/EDTA-
ATPase) of S1 were measured by the determination of
inorganic phosphate release following the method of Fiske
and Subbarow (40), as in Tiago et al. (35). The assays were
carried out at room temperature in 50 mM Tris-HCl (pH
7.9), 2.5 mM ATP, and either 0.23 M KCl and 2.5 mM CaCl2
for Ca2+-ATPase or 0.6 M KCl and 1 mM EDTA for K+/
EDTA-ATPase activities, using 0.1 mg of S1/mL (0.87 íM
S1).
DSC Measurements. DSC measurements were done as
described by Merino and Gutie´rrez-Merino (41). Briefly,
1 Abbreviations: ADPâV1, adenosine 5′-diphosphate-orthovanadate;
DSC, differential scanning calorimetry; DNPH, 2,4-dinitrophenylhy-
drazine; DTNB, 5,5′-dithiobis(2-nitrobenzoate); DTT, dithiothreitol;
EDTA, ethylenediaminetetraacetic acid; GSH, reduced glutathione;
Hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; IC50, inhibi-
tor concentration required to produce 50% inhibition; IAF, 5-(iodoac-
etamido)fluorescein; Pi, inorganic phosphate; M**âADPâPi, intermediate
transient state of F-actin-stimulated myosin-ATPase activity; S1, myosin
subfragment 1; SDS, sodium dodecyl sulfate; SIN-1, 3-morpholino-
sydnonimine; SOD, superoxide dismutase; TCA, trichloroacetic acid;
Tris, tris(hydroxymethyl)aminomethane hydrochloride; U, amount of
enzyme that releases 1 ímol of product per minute.
Inhibition of Myosin by Peroxynitrite Biochemistry, Vol. 45, No. 11, 2006 3795
scanning-calorimetry measurements were carried out using
a MicroCal MC-2 differential scanning calorimeter, operated
at a scanning rate of 60 °C/h under nitrogen pressure of
1.5-2 kg/cm2 during the scan. To minimize the pH change
due to the large enthalpy of protonation of Tris during the
temperature scan, the buffer used for S1 treatments with
SIN-1 was supplemented with 50 mM Pi before the samples
were loaded in the differential scanning calorimeter (DSC
buffer: 50 mM Pi, 10 mM Tris, and 25 mM KCl (pH 7.35)).
All of the scans reported in this article are representative of
experiments done in triplicate with, at least, duplicate S1
preparations. The analysis of the calorimetric data was carried
out with Origin software developed by MicroCal (Northamp-
ton, MA). The curve fitting used Marquadt methods on the
basis of nonlinear least squares, which improved the esti-
mates for each parameter using an iterative process until there
was no further improvement of the fit (minimum value ł2).
Measurements of Cys Oxidation, Nitro-Tyr Formation, and
Protein Carbonyls. The titration of S1 cysteines was done
with DTNB, as indicated in previous works (21, 42), using
an extinction coefficient at 412 nm of 12 000 M-1âcm-1 for
the colored product, thionitrophenolate. S1 cysteines were
measured with 0.5 mM DTNB and an S1 concentration of
0.5 mg of protein/mL in 10 mM Tris and 25 mM KCl (pH
8.5). The increase in absorbance at 412 nm was continuously
recorded for 10 min and then treated with 1% SDS and
heated for 5 min at 80 °C, and the absorbance was measured
after cooling for 15-30 min until a steady value was reached.
The extent of nitrotyrosine formation was measured
spectrophotometrically, using an extinction coefficient at 415
nm of 2800 M-1âcm-1, determined from measurements of
pure 3-nitrotyrosine solutions prepared by weight in the
buffer used for the treatment of S1 with SIN-1. In addition,
nitrotyrosine formation was also assessed by Western blotting
of SDS-PAGE as indicated by Gutie´rrez-Martin et al. (43).
SDS-PAGE of S1 was performed in 12% polyacrylamide
gel.
Protein carbonyl formation was measured spectrophoto-
metrically using DNPH as in Dalle-Donne et al. (44). Briefly,
the protein sample (2 mg/mL) was divided into two 1 mL
aliquots: a test and a blank. The test aliquot was reacted
with 1 mL of 10 mM DNPH in 2 M HCl, and the blank
aliquot was reacted only with 2 M HCl for 1 h in the dark
at room temperature while vortexing every 10 min. The
samples were precipitated with 20% TCA (final concentra-
tion) and centrifuged for 5 min at 1500g. The supernatants
were discarded and the protein pellets washed once more
with 10% TCA and then washed three times with 1 mL
portions of ethanol/ethyl acetate (1:1, v/v). The final pellets
were resuspended in 1 mL of 6 M guanidine hydrochloride
(dissolved in 20 mM phosphate buffer, pH 2.3) at 37 °C for
15 min with vortexing. Carbonyl contents were estimated
by the difference in absorbance at 366 nm (test - blank)
using a molar absorption coefficient of 22 000 M-1âcm-1.
Labeling of S1 at Cys707 with 5-(Iodoacetamido)fluorescein
(IAF). S1 was labeled at Cys707 with IAF as indicated in a
previous study (35), following the protocol indicated in the
procedure (34, 45). Prior to labeling, S1 was first dialyzed
against 0.12 M KCl and 25 mM Tris-HCl at pH 8.0. The
dialyzed sample was then incubated with a 4-5-fold molar
excess of IAF at room temperature for 30 min in the dark.
The unreacted probe was subsequently removed on a
Sephadex G-50 column equilibrated with 0.12 M KCl and
25 mM Tris-HCl at pH 7.0.
Measurements of Hydrogen Peroxide. Hydrogen peroxide
measurements have been done with an Amplex Red/
horseradish peroxidase assay, as indicated in the Molecular
Probes Handbook of Fluorescence Probes and Research
Products (9th ed.).
Statistical Analysis of Experimental Results. All of the
experimental results have been confirmed with three different
S1 myosin preparations, and for each S1 myosin preparation,
measurements have been done, at least, by duplicate (i.e., n
g 6 for each data point). The data plotted in the Figures are
the averages, and the error bars shown are the standard
deviations. Lines drawn in the figures of inhibition of the
S1 ATPase activities as a function of SIN-1 concentration
are the best nonlinear least-squares two-parameter fit to the
equation V ) V0 - (Imax[SIN-1]/IC50 + [SIN-1]), where Imax
(the maximum inhibition) and IC50 are the two iterative
parameters used for the nonlinear least-squares fit, V0 is the
ATPase activity before treatment with SIN-1, and V is the
ATPase activity after treatment with each SIN-1 concentra-
tion.
Chemicals. Chemicals used to prepare buffers were reagent
grade. Ammonium metavanadate was purchased from Riedel-
de-Ha¨en (Germany). ATP, ADP, DNPH, DTNB, DTT,
NADH, 3-nitrotyrosine, phosphoenolpyruvate, 3-morpholi-
nosydnonimine (SIN-1), trypsin, and R-chymotrypsin were
supplied by Sigma Chemical Co. (St. Louis, MO). Pyruvate
kinase and lactate dehydrogenase were purchased from
Roche Molecular Biochemicals (Mannheim, Germany).
5-(Iodoacetamido)fluorescein (IAF) was supplied by
Molecular Probes (Eugene, OR). Monoclonal anti-(3-nitro-
tyrosine) Ig was purchased from Calbiochem (catalog number
487923, La Jolla, CA), and the secondary IgG conjugated
with horseradish peroxidase was supplied by Pierce (Rock-
ford, IL).
GSH and ascorbate solutions were freshly prepared by
weight and in the case of GSH brought to pH 7.0 ( 0.1
with KOH, placed on ice immediately after preparation, and
used for experimental handling within 1 h of preparation.
The GSH concentration was routinely tested with DTNB as
indicated above for cysteine quantification, and the concen-
tration of ascorbate was monitored with measurements of
the absorbance at 265 nm, using an extinction coefficient of
14 500 M-1âcm-1 (46).
Decomposed SIN-1 was prepared, leaving a solution of
SIN-1 (1-10 mM) in buffer of 10 mM Tris and 25 mM
KCl (pH 8.5) to stand at room temperature for 12 h.
RESULTS
Inhibition of S1 ATPase by SIN-1 and Synthetic Peroxy-
nitrite. Incubation of S1 with SIN-1 resulted in a time-
dependent inhibition of the F-actin-stimulated S1 Mg2+-
ATPase activity which closely followed the kinetics of
peroxynitrite release upon SIN-1 decomposition (Figure 1).
The data shown in Figure 1A fit reasonably well to a single-
exponential decay, with a half-time for F-actin-stimulated
S1 ATPase inhibition of 37.5 ( 3.5 min, and a half-time of
42 ( 2 min can be derived for SIN-1 decomposition from
Figure 1B. The following results further supported the fact
that inhibition of F-actin-stimulated S1 Mg2+-ATPase activity
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is due to exposure to the peroxynitrite released by SIN-1.
(i) Incubation with decomposed SIN-1 did not produce a
significant inhibition of this activity, that is, less than 10%
inhibition, and (ii) addition of 3000 U of SOD plus 1500 U
of catalase before SIN-1, at concentrations that efficiently
remove the superoxide anion and prevent peroxynitrite
production as assessed with the NADH assay (25, 47), largely
protected against the inhibition of this activity. Thus, the
results shown in Figure 1 yield an apparent IC50 for F-actin-
stimulated S1 ATPase of 45 ( 5 íM SIN-1 under the
assumption of rapid inhibition upon reaction of S1 with
released peroxynitrite. Because the activity assay of S1
treated with peroxynitrite was diluted 20-fold (from 8.7 to
0.45 íM), the remaining undecomposed SIN-1 added to the
assay medium was lower than 5 íM for 100 íM SIN-1 at
the shortest times measured. The possibility that the reaction
of S1 with peroxynitrite may elicit a delayed inhibition on
S1 or that remaining SIN-1 added with S1 to the assay
medium can react with F-actin or other proteins present in
the assay medium (pyruvate kinase or lactate dehydrogenase)
could not be excluded solely on the basis of the results in
Figure 1, and this encouraged further assessment of the IC50
value for SIN-1.
To experimentally question these points, we have exposed
S1 to different SIN-1 concentrations for 2 h, a time in which
more than 95% of the peroxynitrite derived from SIN-1
decomposition would have already been released (Figure 1B).
The results of the inhibition of the F-actin-stimulated S1
Mg2+-ATPase activity with different SIN-1 concentrations
are shown in Figure 2A, and the activity remaining after
treatment with different SIN-1 concentrations for 2 h was
steady for at least 1 h after the end of the treatment, thus
excluding a slow-developing kinetic-inhibition process. The
results shown in Figure 2A yield an IC50 value of 46.7 (
8.3 íM SIN-1, which is identical to the value derived from
the results shown in Figure 1 and strongly supports the fact
that the inhibition produced by peroxynitrite is due to a fast
reaction between peroxynitrite and S1. Also included in
Figure 2A is the lack of inhibition by treatment with
decomposed SIN-1 and the protection by SOD and (SOD +
catalase) against inhibition by SIN-1. As exposure to
superoxide anion fluxes of 1 and 2 ímol of O2â-/min (up to
a total 200 ímol of O2â-) generated by xanthine/xanthine
oxidase did not inhibit the F-actin-stimulated S1 ATPase
activity (results not shown), the protection afforded by SOD
can be rationalized only in terms of a blockage in the
formation of peroxynitrite, a superoxide anion-derived
inhibitor produced during SIN-1 decomposition. These results
also excluded a significant contribution of direct inhibition
by the nitric oxide released during SIN-1 decomposition
below 200 íM SIN-1, and the 15-20% inhibition obtained
with 200 íM SIN-1 in the presence of SOD plus catalase is
in good agreement with the reported inhibition of the F-actin-
stimulated S1 Mg2+-ATPase by millimolar concentrations
of nitric oxide-releasing agents (48). In addition, when the
pH of the medium is controlled to avoid a significant increase
in pH (e.g., less than 0.02 pH), the inhibition of F-actin-
stimulated S1 Mg2+-ATPase activity by SIN-1 was found
to be the same in the absence and presence of 25 mM
bicarbonate (Figure 2A). Because it has been shown that
hydrogen peroxide can be produced from peroxynitrite
decomposition in some buffers (49), we have measured the
concentration of hydrogen peroxide using the Amplex red
assay at different times of exposure and found it to be 3.7
( 0.2 and 8.9 ( 0.3 íM after 2 h of exposure of S1 to 50
and 200 íM SIN-1, respectively. Titration with H2O2 of the
F-actin-stimulated S1 Mg2+-ATPase activity yielded an IC50
of 0.1 mM H2O2 for inhibition of this activity (data not
shown), therefore excluding a significant contribution of
hydrogen peroxide to the inhibition produced by SIN-1, a
conclusion that was also supported by the lack of protection
by catalase against inhibition by SIN-1 (Figure 2A).
S1 can also be inhibited by treatment with single pulses
of peroxynitrite added under vortexing (Figure 2B) but with
much lower efficiency because of its rapid decomposition
before attaining a proper mixing of the solution, as shown
by the enhanced inhibition when the same total peroxynitrite
is added in pulses of lower concentration (Figure 2B) (43,
50). Figure 2C shows that incubation of S1 with substrate
analogue Mg2+âADPâV1 afforded partial protection against
the inhibition of F-actin-stimulated S1 Mg2+-ATPase
activity by SIN-1. Therefore, these results suggested that S1
FIGURE 1: Time-dependent inhibition of F-actin-stimulated S1
Mg2+-ATPase activity by SIN-1 (A) and kinetics of peroxynitrite
production during SIN-1 decomposition (B). (A) Inhibition of
F-actin-stimulated S1 Mg2+-ATPase activity by 100 íM SIN-1.
S1 (8.7 íM) was treated with 100 íM SIN-1 in buffer, 10 mM
Tris, and 25 mM KCl (pH 8.5) at 25 °C, and aliquots of 50 íL
were pooled at the times indicated in the abscissa and assayed for
activity in 1 mL of reaction medium (indicated in Materials and
Methods) supplemented with 2 íM F-actin. The line is the best fit
of the data to a first-order-exponential-decay function. (B) Kinetics
of peroxynitrite production during the decomposition of 100 íM
SIN-1 in buffer, 10 mM Tris, and 25 mM KCl (pH 8.5) at 25 °C,
measured from the kinetics of NADH oxidation as indicated in
Materials and Methods. Inset: Flux rate of peroxynitrite production
(íM/min) during the decomposition of 100 íM SIN-1, calculated
from the slope of the data shown in panel B at different times (with
1 min intervals).
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inhibition can be due to the reaction of SIN-1-derived
peroxynitrite with amino acids located in the catalytic
domain.
Cys Oxidation during Exposure of S1 to SIN-1. It has been
reported that S1 has two highly reactive cysteines, Cys707
and Cys697, whose oxidation leads to the inhibition of F-actin-
stimulated S1 Mg2+-ATPase activity and also to an altered
pattern of Mg2+-ATPase as well as nonphysiological Ca2+-
ATPase and K+/EDTA-ATPase activities of S1 (28, 45, 51,
52). Briefly, oxidation of Cys707 produces an increase of
nonphysiological Ca2+-ATPase myosin activity, whereas
oxidation of both reactive cysteines inhibits all of the myosin-
ATPase activities (45). However, peroxynitrite-induced
oxidation of highly reactive cysteines is one of the most
established protein-chemical modifications induced by this
reagent (12, 16, 50). Figure 3A shows that exposure to SIN-1
results in inhibition of K+/EDTA-ATPase and Ca2+-ATPase
activities of S1 with IC50 values close to that found for the
inhibition of F-actin-stimulated Mg2+-ATPase activity and
FIGURE 2: Dependence of the inhibition of F-actin-stimulated S1
Mg2+-ATPase activity upon the concentration of SIN-1 (A) and
the number of micromolar pulses of synthetic peroxynitrite (B).
(A) S1 (8.7 íM) was treated with the concentrations of SIN-1
indicated in the abscissa in buffer, 10 mM Tris, and 25 mM KCl
(pH 8.5) at 25 °C (b) or in this buffer supplemented with
decomposed SIN-1 (0), 3000 U of SOD with or without 1500 U
of catalase (O), only 1500 U of catalase (9), or 25 mM bicarbonate
(4), and after 2 h, the aliquots were pooled for assaying the activity
as indicated in the legend of Figure 1A. The effects of catalase
and bicarbonate were found to be not statistically significant by an
analysis of variance test (p > 0.05). (B) S1 (8.7 íM) in buffer, 0.5
M Tris, and 25 mM KCl (pH 7.2) at room temperature was treated
with a different number of pulses of synthetic peroxynitrite
(ONOO-) to reach 1 mM total concentration of peroxynitrite. The
lowest concentration of peroxynitrite used per pulse was 20 íM (n
) 50 pulses). The peroxynitrite pulses were done under vortexing
with a total S1 solution volume of 1 mL, and the samples were
pooled for assay of activity 10-15 min after the treatment with
synthetic peroxynitrite. (C) Partial protection by 0.2 mM ADPâV1
against inhibition of F-actin-stimulated S1 Mg2+-ATPase activity
by 2 h of treatment with SIN-1 (3). S1 was incubated with
0.2 mM ADPâV1 for 30 min before treatment with SIN-1, which
was done as indicated for panel A. The results for S1 treated
with SIN-1 in the absence of ADPâV1 (control) are also included
to allow for direct comparison (b), and the differences were
found to be statistically significant by an analysis of variance test
(*p < 0.001).
FIGURE 3: Inhibition of Ca2+- and K+/EDTA-ATPase activities of
S1 by SIN-1 (A) and the effect of treatment with SIN-1 on the
IAF-labeling of S1 (B). (A) S1 (8.7 íM) was treated with the
concentrations of SIN-1 indicated in the abscissa in buffer, 10 mM
Tris, and 25 mM KCl (pH 8.5) at 25 °C (2, b) or in this buffer
supplemented with catalase (4, O). The circles and triangles stand
for Ca2+- and K+/EDTA-ATPase activities, respectively. The
activities measured before the addition of SIN-1, 1.5 ( 0.2 and
3.5 ( 0.8 ímol of product min-1 (mg of S1)-1 for Ca2+-ATPase
and K+/EDTA-ATPase, respectively, were taken as 100%. The
difference between the inhibition of K+/EDTA-ATPase activity by
SIN-1 in the absence and presence of catalase was found not to be
statistically significant by an analysis of variance test (**p > 0.05).
(B) Fractional inhibition of S1 K+/EDTA-ATPase (b) and fractional
loss of the labeling of S1 at Cys707 by IAF (O) after 2 h of treatment
with the SIN-1 concentrations indicated in the abscissa. S1 K+/
EDTA-ATPase activity and IAF-S1 labeling were measured with
aliquots of the same SIN-1-treated S1 samples. The data shown
are the results of an experiment done in triplicate.
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that H2O2 produced during SIN-1 decomposition produced
at most 10% inhibition of these ATPase activities, as shown
by the difference of inhibition by SIN-1 in the absence and
presence of catalase.
The oxidation of S1 cysteines during exposure to SIN-1
was confirmed by S1 cysteine titration with DTNB. The
results obtained are listed in Table 1 and suggest that
exposure to SIN-1 concentrations that produced approxi-
mately 60% inhibition of F-actin-stimulated S1 Mg2+-
ATPase activity resulted in oxidation of more than 3 mol of
cysteine/mol of S1 (treatment with 50 íM SIN-1). Moreover,
because Cys707 and Cys697 are highly reactive and exposed
at the water/protein interface of the 3D structure of S1 (45,
53, 54), we have also quantified the decrease in fast-reacting
cysteines against DTNB upon treatment with SIN-1 (Table
1), and the results suggest that 50 íM SIN-1 produced the
oxidation of 1.5 mol of very accessible cysteines/mol of S1.
This is in good agreement with the conclusions reached on
the basis of Ca2+-ATPase and K+/EDTA-ATPase activity
measurements (see above). Because S1 can be selectively
labeled by IAF at Cys707 (34, 35, 45), its oxidation by SIN-1
can also be monitored by the parallel decrease of the extent
of labeling of S1 by IAF under the standard experimental
conditions indicated in Materials and Methods. The results
shown in Figure 3B fully confirmed this point and also
demonstrated a tight correlation between the fractional
decrease of the extent of labeling of Cys707 with IAF and
the fractional decrease of the S1 K+/EDTA-ATPase activity.
In addition, a more extensive cysteine oxidation is
observed upon exposure to higher SIN-1 concentrations,
reaching an oxidation of 7.5 of the 10 cysteines of S1 after
treatment with 500 íM SIN-1 for 2 h.
Effect of SIN-1 on the Thermal Stability of S1. An
extensive oxidation of protein cysteines can produce a large
distortion of the folded native structure of a protein,
eventually leading to a partially unfolded protein. This point
was experimentally tested using DSC, a technique that has
been shown to be very valuable for monitoring and quantify-
ing protein conformational transitions during the protein-
unfolding process (41, 55). To have a good signal-to-noise
ratio, the DSC measurements have been done with 2.4 mg
of S1 protein/mL, a concentration 2.4-fold higher than that
used for the activity measurements shown in Figure 1.
The treatment of S1 with SIN-1 largely decreased the
enthalpy of unfolding of S1 (Figure 4A and Table 2) parallel
to the inhibition of the F-actin-stimulated S1 Mg2+-ATPase
activity at this S1 concentration (Figure 4B). The thermal
unfolding of S1 is irreversible under the experimental
conditions used in this study because a re-scan of S1 yielded
a flat baseline (data not shown), a result that is in good
agreement with previously reported studies on S1 thermal
unfolding (56, 57). An analysis of the DSC data (Table 2)
suggests that the unfolding conforms to a non-two-state
irreversible process with only a small decrease in critical-
unfolding temperature (Tc) of less than 0.4 °C, for example,
after treatment of S1 with 500 íM SIN-1 with only a small
decrease in the cooperative unit, as shown by the ¢Hv values
listed in Table 2. Therefore, the DSC results suggest that
the treatment with the highest SIN-1 concentrations used in
this study produced a partially unfolded S1. This point was
confirmed by the increased susceptibility to tryptic digestion
of S1 treated with SIN-1 with respect to the control (untreated
S1) (Figure 4C,D). Because S1 treatment with 250-500 íM
SIN-1 produced an extensive oxidation of S1 cysteines, and
this can lead to a partially unfolded S1, we have carried out
DSC scans of S1 samples treated with SIN-1 in the presence
of intracellular-thiol-protecting antioxidant GSH. GSH
(2 mM) was found to completely protect against SIN-1-
induced partial unfolding of S1 (Table 2).
Binding of the ADPâV1 complex upon incubation with S1
shifts this protein to a conformational state that simulates
the intermediate catalytic state S1âADPâPi (31, 32), and it
has been shown to largely stabilize this domain against
thermal unfolding, that is, it increases the Tc value nearly
10 °C (57, 58). Because the treatment with SIN-1 produced
the oxidation of highly reactive cysteines that are located in
the catalytic domain close to the catalytic center of S1 (see
above), we considered the possibility that the distortion of
the catalytic site induced by treatment with SIN-1 could lead
to the impairment of the ability of S1 to reach the intermedi-
ate state S1âADPâPi. The results shown in Figure 4E
demonstrate that this is indeed the case, as treatment for 2 h
with 500 íM SIN-1 decreased the ratio between the
enthalpies of the peaks of Tc of 57 ( 0.5 and 49 ( 1 °C
from 3.3 ( 0.1 to 0.50 ( 0.05. This effect of SIN-1 is not
produced by decomposed SIN-1 (results not shown), sug-
gesting that it is not due to long-lived products generated
during SIN-1 decomposition. Therefore, these results indicate
that treatment of S1 with SIN-1 results in a large decrease
of the conformational flexibility of the catalytic domain of
S1.
Protein Carbonyl and 3-Nitrotyrosine Formation during
Exposure of S1 to SIN-1. In addition to cysteine oxidation,
treatment of proteins with peroxynitrite can also produce
protein carbonyls and 3-nitrotyrosine formation (9, 14, 59).
Therefore, the possibility that these modifications can be
underlying the functional impairment of S1 observed after
treatment with SIN-1 deserves to be studied.
The results of the measurements of protein carbonyls in
S1 before and after treatment with SIN-1 leading to an
inhibition close to 90% of the F-actin-stimulated S1 Mg2+-
ATPase activity are shown in Figure 5A and allowed us to
conclude that the increase of S1 protein carbonyls elicited
by treatment with SIN-1 is lower than 0.1 nmol of protein
carbonyls/mol of S1. Therefore, protein carbonyl formation
is unlikely to play a significant role in the inhibition of
F-actin-stimulated S1 Mg2+-ATPase activity and in the




(nmol of Cys/mol of S1)
total Cys
(nmol of Cys/mol of S1)
0 1.96 ( 0.41 10.1 ( 0.6
50 0.47 ( 0.12 6.6 ( 0.3
100 0.36 ( 0.04 5.6 ( 0.3
250 0.28 ( 0.03 4.0 ( 0.2
500 0.09 ( 0.05 2.6 ( 0.3
a S1 cysteines were quantified by titration of 0.5 mg of S1 protein
with 0.5 mM DTNB after incubation of S1 (8.7 íM) for 2 h with the
concentrations of SIN-1 listed above. Very accessible cysteines refer
to the cysteines that reacted in less than 1 min, calculated from the
increase of absorbance recorded 1 min after DTNB addition, and the
total cysteine values were determined after the samples were treated
with 1% SDS (added as a solid to the solution). See Materials and
Methods for further experimental details.
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impaired conformational response to ADPâV1 of SIN-1-
treated S1.
Nitrotyrosine formation after the treatment of S1 with
SIN-1 was detected and quantified (Figure 5B), although the
FIGURE 4: Effect of the treatment of S1 with SIN-1 on the thermal unfolding of S1 and the ability of ADPâV1 to shift S1 to the intermediate
conformational state M**âADPâPi. (A) Representative DSC traces of S1 (21 íM) treated with indicated SIN-1 concentrations for 2 h in
buffer, 10 mM Tris, and 25 mM KCl (pH 8.5) at 25 °C. (The buffer is described in the legend for Figure 1A.) To minimize the pH change
during the temperature scan after the treatment with SIN-1, the samples were placed in the DSC buffer indicated in Materials and Methods,
and the scans were performed at a rate of 60 °C/h. (B) Inhibition of the F-actin-stimulated Mg2+-ATPase activity of 21 íM S1 by SIN-1
after 2 h of treatment with the SIN-1 concentrations indicated in the abscissa using the experimental conditions indicated for the data shown
in panel A. (C) Coomassie blue stained SDS-PAGE of partially digested S1 before and after treatment with SIN-1. S1 (8.7 íM) was
treated with the indicated SIN-1 concentrations for 2 h in buffer, 10 mM Tris, and 25 mM KCl (pH 8.5) at 25 °C and, thereafter, partially
digested with trypsin (molar ratio of 1:50 relative to S1) for 30 min. SDS-PAGE was performed in 12% polyacrylamide gels with 10 íg
of S1 protein loaded per lane, and the molecular weight markers were loaded in the left and right lanes labeled with HMW and LMW (high
and low molecular weight markers), respectively. (D) The ratio between the intensities of the bands of 50 and 75 (ratio 50/75) is plotted
as a function of SIN-1 concentration. (E) Representative DSC traces of S1 (21 íM) in a DSC buffer supplemented with 0.2 mM Mg2+
ADPâV1 and incubated for 30 min before starting the scan. (a) Control, not treated with SIN-1, and (b) S1 treated with 500 íM SIN-1 for
2 h in the buffer indicated for panel A. Dotted lines are the best fits to a two-peak non-two-state transitions obtained with MicroCal Origin
software.
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level of nitrotyrosines in S1 is lower than 0.05 mol of
3-nitrotyrosine/mol of S1 after treatment for 2 h with 50 íM
SIN-1, which resulted in a 50-60% loss of F-actin-stimulated
S1 Mg2+-ATPase activity. Furthermore, after 2 h of treatment
with 500 íM SIN-1, which resulted in more than a 90%
loss of F-actin-stimulated S1 Mg2+-ATPase activity, only
0.7 mol of nitrotyrosine/mol of S1 is produced. Therefore,
these results only support at most a marginal role of
nitrotyrosine formation in the inhibition of F-actin-stimulated
S1 Mg2+-ATPase activity during treatment of S1.
Despite the low level of 3-nitrotyrosine formation, we
decided to monitor the protein domain in which this oxidative
protein modification takes place to critically evaluate the
possibility of its implication in the blockage by SIN-1
treatment against the ADPâV1-induced conformational shift.
It has been shown that mild tryptic digestion of S1 leads to
a specific protein fragmentation that allows the resolving of
each of the major functional protein domains of S1 in SDS-
PAGE (54, 60). Thus, tryptic S1 fragments were analyzed
by Western blot to detect 3-nitrotyrosine formation in S1
treated with chemically synthesized ONOO- and its tryptic
fragments. The results (not shown) indicate that 3-nitroty-
rosines appear to be located in the 25 kDa tryptic fragment,
one of the catalytic domain-derived protein fragments that
contains several tyrosines (53, 54).
Protection by the Antioxidants GSH, NADH, and Ascor-
bate against Inhibition by SIN-1 of F-Actin-Stimulated S1
Mg2+-ATPase ActiVity. Figure 6 shows that major antioxi-
dants present in normal muscle cells protect against the
inhibition of F-actin-stimulated S1 Mg2+-ATPase activity by
SIN-1-derived peroxynitrite. Significant protection can be
attained with 100 íM GSH or ascorbate, whereas NADH
affords only approximately 50% protection. In addition, GSH
and ascorbate have similar high efficiencies as protecting
agents because their concentrations that produce half protec-
tion (IC50) are close to the concentration of SIN-1 (50 íM).
Because the redox chemistry of ascorbate with reactive
oxygen species (like the superoxide anion) is complex, owing
to the formation of the ascorbate free radical (61), to exclude
the possibility that in this case the protection could be due
to interference with peroxynitrite formation during SIN-1
decomposition rather than to real protection against peroxy-
nitrite, we have also studied the dependence on ascorbate
concentration of the inhibition of the F-actin-stimulated S1
Mg2+-ATPase activity by one pulse of 500 íM synthetic
peroxynitrite. The results are shown in Figure 6B and indicate
that ascorbate significantly protects against the inhibition of
S1 by peroxynitrite, with an IC50 value of 100 íM.
DISCUSSION
Exposure of S1 to SIN-1 produced a time-dependent
inhibition of F-actin-stimulated S1 ATPase activity that
correlated with the kinetics of peroxynitrite generation upon
SIN-1 decomposition. The following experimental observa-
tions demonstrated that peroxynitrite was the agent causing
this inhibition: (1) blockage of inhibition upon exposure to
SIN-1 by SOD + catalase but not by catalase alone; (2) the
lack of an effect of incubation with decomposed SIN-1; and
(3) inhibition by treatment with micromolar pulses of
chemically synthesized peroxynitrite. The obtained IC50 value
for the inhibition by SIN-1 was 46.7 ( 8.3 íM SIN-1 with
8.7 íM S1 and 120 ( 10 íM SIN-1 with 21 íM S1, that is,








S1 (control)b 47.6 ( 0.1 245 ( 6 131 ( 2
S1 + 200 íM SIN-1 47.4 ( 0.1 189 ( 9 123 ( 2
S1 + 500 íM SIN-1 47.2 ( 0.1 136 ( 10 124 ( 2
S1 + 2 mM GSH 47.6 ( 0.1 235 ( 8 149 ( 2
S1 + 2 mM GSH + 500 íM SIN-1 47.7 ( 0.1 210 ( 6 146 ( 2
a S1 (21 íM) was treated with the listed concentrations of SIN-1 for 2 h in the absence and presence of 2 mM GSH before being loaded into
the calorimeter. DSC data were fit to a non-two-state transition with the Origin software of the MicroCal MC2 differential scanning calorimeter,
which yielded Tc, the critical temperature of unfolding; ¢H, the enthalpy of unfolding; and ¢Hv, the van’t Hoff enthalpy that can be taken as an
index of the cooperativity of unfolding for slow, irreversible unfolding processes (55). Further experimental details are given in Materials and
Methods. b The same results were obtained with S1 treated with the addition of 500 íM decomposed SIN-1.
FIGURE 5: Protein carbonyl and 3-nitrotyrosine formation during
the treatment of S1 with SIN-1. (A) Protein carbonyls as a function
of the time of treatment of S1 (8.7 íM) with 100 íM SIN-1 in
buffer, 10 mM Tris, and 25 mM KCl (pH 8.5) at 25 °C. The proteins
carbonyls were measured as indicated in Materials and Methods.
(B) 3-Nitrotyrosine formation after treatment for 2 h with the SIN-1
concentrations indicated in the abscissa of S1 (8.7 íM) in buffer,
10 mM Tris, and 25 mM KCl (pH 8.5) at 25 °C. The concentration
of 3-nitrotyrosines was measured as indicated in Materials and
Methods.
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50% inhibition with a SIN-1/S1 molar ratio close to 5.5.
Because the generation of peroxynitrite from SIN-1 decom-
position is a slow process (22, 25), showing a half-time of
42 ( 2 min in our experimental conditions, with a peak of
peroxynitrite concentration reaching approximately 1% of
total SIN-1 due to the short life of peroxynitrite in solutions
at pH 7-7.4 (see Figure 1 and Martı´n-Romero et al. (25)),
we concluded that an exposure of 2 h to submicromolar
fluxes of peroxynitrite (peak flux below 1 íM/min) is
sufficient to produce 50% inhibition of F-actin-stimulated
S1 Mg2+-ATPase activity. Recall that submicromolar con-
centrations of peroxynitrite have been reportedly reached in
tissues during the ischemia/reperfusion syndrome and in-
flammation (8, 26), where the duration of the tissue insult
lasts from 30 min to several hours. Moreover, myosin and
creatine kinase are muscle proteins showing higher nitro-
tyrosine content, a peroxynitrite fingerprint marker in cells
and tissues, after ischemia/reperfusion episodes or in aged
muscle (1, 6, 10). This is consistent with the high concentra-
tion of myosin in the sarcoplasm of muscle cells and with
the fact that the IC50 value for inhibition of F-actin-stimulated
S1 Mg2+-ATPase activity by SIN-1 and/or synthetic per-
oxynitrite reported in this article is close to that reported for
the inhibition of creatine kinase (62) and nearly 4-fold
lower than the one reported for another abundant muscle
protein, the sarcoplasmic reticulum Ca2+Mg2+-ATPase
(15, 16, 50).
Our results show that three of the major antioxidants
present in muscle cells (GSH, ascorbate, and NADH) can
significantly protect against S1 inhibition by the peroxy-
nitrite-releasing agent SIN-1 with an IC50/SIN-1 ratio close
to 1 for all of them (IC50 approximately 50 íM for 50 íM
SIN-1), although NADH only affords nearly 50% protection.
These results suggest that in normal physiological conditions
the sarcoplasm concentrations of these antioxidants are high
enough, 5-10 mM GSH, g0.5 mM ascorbate, (63) and
g100 íM (NADH + NADPH) (64), to ensure proper
protection against an acute and short-lived peroxynitrite
insult. However, the increase in the 3-nitrotyrosine content
of myocardial myosin after ischemia/reperfusion (1, 6)
indicates that these antioxidant defenses are largely depleted
near myofibrils during acute oxidative insults, suggesting that
myofibrils are very close to the subcellular sites of peroxy-
nitrite generation. This is indeed the case, as the well-known
sources of superoxide anion are the redox chains of the
mitochondria and plasma membrane (38, 65, 66).
Although 3-nitrotyrosine formation can be detected in S1
treated with SIN-1 or synthetic peroxynitrite, the extent of
this chemical modification of S1 was found to be too low to
account for the inhibition of F-actin-stimulated S1 Mg2+-
ATPase activity, that is, less than 0.05 mol of 3-nitrotyrosine/
mol of S1, when 50% of the activity is lost. The failure of
bicarbonate to enhance the inhibition of F-actin-stimulated
S1 Mg2+-ATPase activity by SIN-1 or synthetic peroxynitrite
is also fully consistent with this conclusion because bicar-
bonate enhances 3-nitrotyrosine formation by peroxynitrite
via a radical pathway involving tyrosyl radical formation after
the attack of CO3â- (7-9). Furthermore, the formation of
protein carbonyls is barely detectable during the treatment
of S1 with SIN-1 concentrations producing more than 90%
inhibition of F-actin-stimulated S1 Mg2+-ATPase activity
(less than 0.1 mol of protein carbonyl/mol of S1). However,
fast-reacting cysteines against DTNB per mole of S1 are
largely oxidized (1.5 over 2, i.e., 75%) during treatments
with SIN-1 producing 60% inhibition of S1 ATPase activi-
ties, and it has been shown that oxidation or chemical
modification of the two highly reactive cysteines of S1,
Cys707 and Cys697, results in strong inhibition of the S1
ATPase activities (28, 45, 51, 52). This point was confirmed
by the tight correlation between the fractional decrease of
the extent of labeling of Cys707 with IAF and the fractional
decrease of S1 ATPase activity after exposure to SIN-1
reported in this article, as ascertained by S1 Cys707 titration
with IAF under well-established experimental conditions (34,
35, 45). These cysteines are located in the catalytic domain
of S1, very close to each other in the 3D structure of a
domain that undergoes significant conformational changes
during the catalytic cycle (53, 54), and the DSC results
reported in this article showed that SIN-1-treated S1 has a
largely impaired ability to attain the conformation of the
obligatory intermediate catalytic state S1âMg2+-ADPâPi,
which in nontreated S1 is induced upon incubation with
Mg2+-ADPâV1 (31, 32). Consistent with this result Mg2+-
ADPâV1 was found to afford partial protection against the
FIGURE 6: Protection by GSH, ascorbate, and NADH against
inhibition of S1 by SIN-1 and synthetic peroxynitrite. (A) Protection
against the inhibition of F-actin-stimulated S1 Mg2+-ATPase activity
by 50 íM SIN-1 by GSH (b), NADH (2), and ascorbate (9). The
samples were assayed for activity after 2 h of incubation of S1
(8.7 íM) with 50 íM SIN-1 at 25 °C in buffer, 10 mM Tris, and
25 mM KCl (pH 8.5) supplemented with the concentrations of the
antioxidants (GSH, NADH, or ascorbate) indicated in the abscissa.
(B) Protection by ascorbate against the inhibition of F-actin-
stimulated S1 Mg2+-ATPase activity by one pulse of 500 íM
synthetic peroxynitrite. Synthetic peroxynitrite was added to S1 (8.7
íM) in buffer, 0.5 M Tris, and 25 mM KCl (pH 7.2) under vortex
at room temperature. The samples were pooled for assay of activity
10-15 min after treatment with synthetic peroxynitrite.
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inhibition of S1 by peroxynitrite. Therefore, the oxidation
of Cys707 and Cys697 can account for the inhibition of F-actin-
stimulated S1 Mg2+-ATPase activity by peroxynitrite through
the blockage of the shift of the catalytic center to reach the
conformation attained in the intermediate S1âMg2+-ADPâPi
state required for the progress of the catalytic cycle. In
conclusion, S1 is inhibited by peroxynitrite acting as a strong
oxidant, whereas peroxynitrite-derived radicals play only a
secondary role in this inhibition.
Interestingly, treatment of S1 with SIN-1 concentrations
producing peroxynitrite fluxes close to or higher than 1 íM/
min (e.g., g100 íM SIN-1) resulted in an extensive oxidation
of S1 cysteines and a partial S1 unfolding at physiological
temperatures, as monitored by the decrease of the enthalpy
of unfolding measured in DSC experiments and the increased
sensitivity to tryptic digestion of SIN-1-treated S1. The full
protection afforded by 2 mM GSH against peroxynitrite-
induced S1 unfolding suggests a major role for cysteine
oxidation in protein structural alterations leading to the
oxidative unfolding of S1. In addition, this oxidative unfold-
ing must lead to a partially unfolded S1 state that does not
rapidly evolve toward a completely unfolded protein because
the activity remaining after treatment of S1 with SIN-1 is
steady for at least 1 h. Because the ability of F-actin to
stimulate S1 Mg2+-ATPase is lost after the treatment of S1
with SIN-1 and the highly reactive cysteines, Cys707 and
Cys697, are close to the active site binding domain in S1, the
simplest hypothesis is that this domain undergoes an oxida-
tive unfolding linked to cysteine oxidation. These peroxy-
nitrite fluxes can be attained in vivo during inflammation
(8, 26), and an acute exposure of myosin to these peroxy-
nitrite fluxes may produce an oxidation-induced irreversible
myosin partial unfolding in cells and tissues. Because
unfolded, oxidized proteins can be rapidly degraded by the
intracellular proteasome (67, 68) and peroxynitrite increases
the degradation of several cellular proteins by the proteasome
(69), taking into account the high concentration of myosin
in muscle cells could explain the significant loss in myo-
fibrillar mass. To the best of our knowledge, this is the first
report of a peroxynitrite-induced oxidative protein unfolding
case, a phenomenon that can allow the rationalization of the
rapid loss of muscle mass after inflammation or ischemic
insults on simple biochemical grounds.
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